EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification

Conan Juan iD, Alec C Bancroft iD, Ji Hae Choi iD, Johanna H Nunez, Chase A Pagani iD, Yen-Sheng Lin iD, Edward C Hsiao iD, Benjamin Levi

Biomolecules · 2024

DOI: 10.3390/biom14030349 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Conan Juan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Organogenesis, Regeneration, and Trauma, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Myositis Ossificans, Ossification, Heterotopic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterotopic ossification (HO) is a debilitating pathology where ectopic bone develops in areas of soft tissue. HO can develop as a consequence of traumatic insult or as a result of dysregulated osteogenic signaling, as in the case of the orphan disease fibrodysplasia ossificans progressiva (FOP). Traumatic HO (tHO) formation is mediated by the complex interplay of signaling between progenitor, inflammatory, and nerve cells, among others, making it a challenging process to understand. Research into the pathogenesis of genetically mediated HO (gHO) in FOP has established a pathway involving uninhibited activin-like kinase 2 receptor (ALK2) signaling that leads to downstream osteogenesis. Current methods of diagnosis and treatment lag behind pre-mature HO detection and progressive HO accumulation, resulting in irreversible decreases in range of motion and chronic pain for patients. As such, it is necessary to draw on advancements made in the study of tHO and gHO to better diagnose, comprehend, prevent, and treat both.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myositis OssificansOssification, HeterotopicHumansOsteogenesisBone and Bones

Stichwörter der Autor:innen

ACVR2ALK2ectopic bonefibrodysplasia ossificans progressivaheterotopic ossificationtrauma

Autor:innen und Institutionen

  • Center for Organogenesis, Regeneration, and Trauma, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Division of Endocrinology and Metabolism, Department of Medicine, the Institute for Human Genetics, and the Program in Craniofacial Biology, University of California San Francisco Medical Center, San Francisco, CA 94143…

ORCID-Profile: Conan Juan, Alec C Bancroft, Ji Hae Choi, Chase A Pagani, Yen-Sheng Lin, Edward C Hsiao

Förderung

  • NIAMS NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Juan, C., Bancroft, A. C., Choi, J. H., Nunez, J. H., Pagani, C. A., Lin, Y. S., Hsiao, E. C., & Levi, B. (2024). Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification. Biomolecules. https://doi.org/10.3390/biom14030349

Vancouver

Juan C, Bancroft AC, Choi JH, Nunez JH, Pagani CA, Lin YS, et al. Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification. Biomolecules. 2024. doi:10.3390/biom14030349

BibTeX
@article{Juan2024,
  author = {Juan, Conan and Bancroft, Alec C and Choi, Ji Hae and Nunez, Johanna H and Pagani, Chase A and Lin, Yen-Sheng and Hsiao, Edward C and Levi, Benjamin},
  title = {Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14030349}
}
Kostenlos starten →